Latest / Investor Exchange / How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Transcript

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025 · Investor Exchange

• 0:02
  Time for another Investor Exchange Podcast. Here are your hosts, Matt and Sally.
• 0:08
  Welcome back. We are so glad you could join us for today's Deep Dove,
• 0:11
  because if you are evaluating the Asian health care sector right now,
• 0:15
  you are going to want to pay very close attention to the stack of freshly released
• 0:19
  documents we're analyzing today. Mm-hmm. We've got a lot to get through.
• 0:23
  We really do. We're looking at materials from late February 2026,
• 0:27
  and our mission today is to cut through the heavy accounting terminology.
• 0:33
  You know, really evaluate the actual financial health and the strategic positioning
• 0:37
  of a major player in the region.
• 0:39
  Right. And we are focusing our analysis entirely on the fiscal year 2025 financial
• 0:43
  results for Raffles Medical Group.
• 0:46
  Which we'll just refer to as RMG throughout this discussion to keep things moving. Exactly.
• 0:50
  RMG. They are a massive integrated health care provider listed on the Singapore Exchange.
• 0:56
  And our source material today includes their official media release,
• 1:00
  their condensed financial statements for the full year, and the independent
• 1:03
  auditor's report provided by KPMG.
• 1:06
  Right. The KTMG report is crucial.
• 1:08
  So our objective is straightforward here. We're examining these documents from
• 1:12
  a pure investor per stand.
• 1:14
  We want to see the real picture. Yeah, we want to identify where their revenue
• 1:18
  and profit growth are actually originating, assess the resilience of their balance
• 1:21
  sheet, and map out the specific risks and long-term opportunities ahead of them.
• 1:26
  And we'll keep the tone clear, neutral, and informative today. Right.
• 1:30
  Okay, let's unpack this, starting with the headline numbers. Let's do it.
• 1:33
  So, looking at the top-line performance for FY 2025, RMG reported revenue of
• 1:39
  $765.3 million Singapore dollars. That represents a 1.8% growth compared to the previous year.
• 1:48
  Right. And a 1.8% increase is, well, it's relatively modest top line growth.
• 1:52
  Yeah. It's not exactly screaming hyper growth. No, it's not.
• 1:55
  However, in corporate financial analysis, top line revenue only tells a fraction of the story.
• 2:01
  The more critical metric for anyone evaluating the health of the business is
• 2:05
  how efficiently that revenue translates into actual profit.
• 2:08
  And that brings us to a key metric featured prominently in their reports.
• 2:12
  You'll see this acronym a lot, PATM, P-A-T-M-I, which stands for Profit After
• 2:17
  Tax and Minority Interests.
• 2:19
  To put it simply for you, after the company pays all its operating expenses,
• 2:22
  settles its tax obligations, and accounts for the share of profits owed to outside
• 2:27
  partners in joint ventures. Which they have a few of. Exactly. Yeah.
• 2:31
  PTMI is that final bottom line profit that belongs entirely to the actual shareholders.
• 2:36
  It's the money that actually matters to you as an investor. What's fascinating
• 2:40
  here is the sheer disparity between the revenue growth and the POTMI growth.
• 2:44
  It's a huge gap. It really is.
• 2:46
  While revenue only ticked up by that 1.8 percent, their PTMI surged by a very robust 13.4 percent.
• 2:53
  Wow. Landing at $70.6 million for the full year.
• 2:57
  That is a textbook example of operational leverage. Furthermore,
• 3:00
  the momentum seemed to accelerate as the year progressed.
• 3:03
  If we isolate just the second half of 2025, the PTMI jumped an impressive 21.7% to $38.5 million.
• 3:12
  Right. And when profit scales at roughly 7 to 10 times the rate of revenue,
• 3:16
  it clearly signals that management is exercising rigorous cost control.
• 3:21
  They are optimizing their operational efficiency across the board. Precisely.
• 3:25
  They are successfully converting a much larger percentage of every incremental
• 3:29
  dollar earned into pure shareholder profit.
• 3:32
  And that level of efficiency cascades directly down to the balance sheet,
• 3:36
  which honestly is currently in a highly defensive position. A fortress,
• 3:40
  really. Yeah, a fortress.
• 3:42
  As of the end of FY 2025, RMG is holding $310.8 million in cash and cash equivalents.
• 3:50
  Which is massive. And in an economic environment that still features fluctuating
• 3:55
  interest rates and macroeconomic uncertainty, holding a cash reserve of that
• 3:59
  magnitude provides significant strategic buffer.
• 4:01
  It provides defensive security, but it also enables proactive capital allocation.
• 4:07
  A robust cash position allows a company to fund internal growth initiatives,
• 4:11
  pursue acquisitions without taking on expensive debt.
• 4:13
  Which is crucial right now. And return capital directly to shareholders.
• 4:17
  And RMG clearly opted for the latter. with the board proposing a final core
• 4:23
  dividend of three-point-year cents per share.
• 4:26
  Which represents a 20% year-on-year increase. But more importantly,
• 4:30
  it translates to an 84% payout ratio based on their sustainable P80MI.
• 4:34
  Distributing 84% of your core profits back to investors is a highly aggressive payout ratio. It is.
• 4:41
  It demonstrates management's supreme confidence in their current cash flow generation.
• 4:45
  They clearly believe they don't need to hoard that capital just to maintain
• 4:49
  their day-to-day operations.
• 4:51
  Right. But to determine if this level of profitability and dividend distribution
• 4:55
  is actually sustainable long-term, we need to dissect the individual operating divisions.
• 4:59
  We need to see where this cash is actually being generated.
• 5:02
  Exactly. So RMG utilizes an integrated healthcare model, meaning their revenue
• 5:07
  streams are diversified across several interconnected divisions. Right.
• 5:10
  The foundation of this model is their hospital services division.
• 5:13
  Revenue in this segment increased by 3.5% to $357.8 million.
• 5:19
  And again, the profit outpaced that top-line growth, rising 15.3% to $41.1 million.
• 5:27
  So what's driving that? The financial statements attribute that 15.3% profit
• 5:31
  expansion to steady patient volumes, an increase in higher average bill sizes,
• 5:36
  and enhanced operational efficiencies across their facilities in both Singapore and China.
• 5:41
  Essentially, the hospitals are treating complex, higher-margin cases,
• 5:45
  and they're managing the fixed costs of running those giant facilities much more effectively.
• 5:50
  So the hospital services segment is the reliable engine. But the most striking
• 5:53
  figures in the entire earnings report come from their insurance division.
• 5:57
  Oh, absolutely. Raffles Health Insurance, or RHI. Right.
• 6:00
  The revenue for RHI grew by a respectable 4.1% to $185.2 million.
• 6:06
  And that was primarily through contract repricing and the acquisition of new corporate contracts.
• 6:11
  The revenue growth is solid, yes, but the profit generation is what really caught my eye.
• 6:16
  That's wild. RHI's profits spiked by an incredible 50.6% year on year.
• 6:21
  Just to give you some context on why that is so shocking, the broader global
• 6:25
  and regional health care insurance industry is currently facing immense pressure
• 6:30
  from medical inflation. Massive pressure.
• 6:33
  The costs of pharmaceuticals, specialized labor, advanced treatments,
• 6:37
  they're all rising sharply. Right, which heavily compresses the profit margins
• 6:41
  of standard standalone insurance companies.
• 6:44
  So a 50.6% profit increase in a highly inflationary environment is anomalous.
• 6:50
  I mean, unless you look at the underlying mechanics of their business model.
• 6:53
  The report's credit discipline claims management and strict expense control.
• 6:58
  But the real advantage is structural, isn't it? Entirely structural.
• 7:01
  Because RMG is an integrated provider, meaning they act as both the insurance
• 7:06
  payer and the health care provider, they effectively eliminate the friction
• 7:10
  and the markups that exist between third-party insurers and independent hospitals.
• 7:14
  That integrated loop is incredibly powerful because if you are a standalone
• 7:18
  insurer, you are constantly negotiating with hospitals that are incentivized
• 7:22
  to bill you for as many tests and procedures as possible. Exactly.
• 7:26
  But RMG, on the other hand, can direct their insurance policyholders to their
• 7:30
  own hospitals and clinics.
• 7:32
  Right. They have total visibility into the care pathway.
• 7:35
  That allows them to eliminate redundant testing, streamline administrative costs,
• 7:39
  and capture the margin at every single step of the patient journey.
• 7:43
  They basically insulate themselves
• 7:45
  from the very market inflation that is harming their competitors.
• 7:48
  Precisely. Now, we also need to review their health care services division,
• 7:53
  which encompasses their network of primary care clinics and general medical
• 7:57
  practices. Right, the clinics.
• 7:59
  The documents note a 3% decline in revenue here, bringing it down to $285.9 million.
• 8:06
  And they attributed this to a general reduction in the consumption of services.
• 8:10
  Now, a contraction in top-line revenue is rarely ideal. But from an investor
• 8:14
  standpoint, the critical detail here is that the profitability of this division
• 8:18
  remained broadly stable. Which is very telling.
• 8:21
  It indicates an agile management team. They quickly recognized the lower patient
• 8:25
  footfall and immediately scaled back variable costs to protect their profit
• 8:28
  margins. Okay, here's where it gets really interesting.
• 8:31
  We have to analyze their geographic diversification.
• 8:35
  Specifically, the China expansion. Yes, China is a major piece of the puzzle.
• 8:40
  RMG has been steadily deploying capital into the Chinese market,
• 8:43
  and the FY 2025 numbers show revenue there, growing by 2.3% to 359.4 million Chinese yuan.
• 8:52
  Which converts to approximately 65.4 million Singapore dollars. Right.
• 8:57
  But beyond the raw revenue figures, the strategic positioning in China is really deepening.
• 9:02
  The reports highlight key operational partnerships with major local institutions.
• 9:06
  We're talking about Shanghai's Renji Hospital, Zongzhan Hospital,
• 9:09
  and Chongqing's first affiliated hospital.
• 9:12
  Partnering with established high-volume public hospitals like that is a very
• 9:15
  methodical way to build local brand credibility.
• 9:18
  It integrates them into the existing medical referral networks,
• 9:21
  and it blends RMG's international clinical standards with deep local market knowledge.
• 9:26
  While the partnerships build the brand, their capital allocation decisions reveal
• 9:30
  their long-term conviction.
• 9:31
  In October of 2025, RMG utilized $16.6 million of their internal cash reserves
• 9:39
  to acquire the remaining 30% stake in Shanghai Kiwa Hospital.
• 9:43
  Right, so they now own it outright as a wholly owned subsidiary.
• 9:48
  Consolidating ownership of a major physical asset in a foreign market using
• 9:51
  cold, hard cash is a definitive statement.
• 9:54
  You do not buy out minority partners unless your internal projections show that
• 9:58
  the asset is approaching a significant inflection point in profitability. Exactly.
• 10:03
  By moving to 100% ownership, RMG is ensuring that all future upside and free
• 10:08
  cash flow generated by that hospital will accrue entirely to their shareholders.
• 10:13
  Zero leakage to joint venture partners. Zero.
• 10:16
  So having analyzed the management's reported figures and strategic narrative,
• 10:19
  our next step is to examine the independent auditor's report from KPMG.
• 10:23
  For any thorough financial analysis, the auditor's report serves as a critical reality check.
• 10:28
  It verifies that the numbers presented are grounded in accepted accounting principles.
• 10:32
  KPMG issued an unqualified opinion, which is commonly known as a clean bill
• 10:37
  of health. Which is what you want to see. Definitely.
• 10:40
  However, they dedicated significant
• 10:42
  sections of their report to outlining several key audit matters.
• 10:46
  And it is important to clarify for you listening that a key audit matter is
• 10:50
  not an accusation of wrongdoing. It's not a red flag.
• 10:53
  Right. It just denotes an area within the financial statements that involves
• 10:56
  a high degree of complexity, management judgment, or forecasting.
• 11:01
  Areas which naturally required the auditors to apply enhanced scrutiny.
• 11:05
  Right. The first key audit matter highlighted by KPMG involves RMG's investment properties.
• 11:10
  RMG holds $233.6 million in investment properties.
• 11:15
  These are primarily commercial spaces and shop units in Singapore, right? Yes.
• 11:18
  And in FY 2025, RMG recorded a $4.7 million fair value gain on these properties.
• 11:25
  Okay. And that $4.7 million gain flows directly into the income statement,
• 11:29
  and boosts the overall profit figure we discussed earlier. It does.
• 11:33
  But until a property is actually sold, that gain only exists on paper.
• 11:36
  It is an unrealized gain based on an estimated valuation.
• 11:40
  Which is exactly why KPMG focused so heavily on it.
• 11:43
  Real estate valuation relies on a complex matrix of assumptions.
• 11:47
  You're looking at projected rental yields, occupancy rates, capitalization rates.
• 11:52
  So what did KPMG do about it?
• 11:53
  KPMG utilized external valuation specialists to rigorously test management's
• 11:58
  assumptions against current macroeconomic data.
• 12:01
  They needed to ensure that $4.7 million gain was structurally sound and not
• 12:06
  just the result of overly optimistic internal modeling. Makes sense.
• 12:11
  And KPMG applied a similar level of rigor to RMG's massive portfolio of physical
• 12:16
  hospitals, which are classified on the balance sheet as property,
• 12:20
  plant, and equipment, or PPE.
• 12:22
  And that line item stands at a staggering $741.3 million.
• 12:28
  Mostly driven by the capital-intensive hospital developments in China.
• 12:31
  Right. And when a company carries three-quarters of a billion dollars in physical
• 12:34
  assets, auditors must constantly test for impairment indicators.
• 12:38
  An impairment test essentially evaluates whether the carrying value of the hospital
• 12:41
  on the balance sheet is higher than its recoverable amount.
• 12:44
  Which is the present value of all the future cash flows that hospitals is expected to generate.
• 12:50
  Right. So if the China hospitals were to struggle with patient acquisition or
• 12:53
  face unforeseen regulatory hurdles that permanently cap their earning potential,
• 12:57
  the future cash flows would drop.
• 13:00
  And if those cash flows drop below the $741.3 million carrying value.
• 13:06
  RMG would be forced to take a massive write-down.
• 13:09
  Which would devastate their reported profits. Exactly.
• 13:11
  So the fact that KPMG aggressively stress-tested the valuation methodologies
• 13:16
  and future cash flow projections for the China hospitals without requiring a major write-down
• 13:21
  provides significant validation of RMG's expansion strategy.
• 13:25
  The auditors also evaluated two other highly technical areas.
• 13:29
  They reviewed RMG's $7.7 million in goodwill, noting a minor impairment loss
• 13:34
  of $316,000 recognized during the year.
• 13:37
  But more importantly, they scrutinized the $64.6 million held in insurance contract liabilities.
• 13:43
  Right. Insurance liabilities represent the estimated future cost of paying out
• 13:47
  medical claims for current policyholders. And calculating this requires incredibly
• 13:52
  complex actuarial science.
• 13:54
  You're analyzing historical claims data, predicting medical inflation rates,
• 13:59
  and modeling future patient behavior.
• 14:01
  So knowing that an independent firm like KPMG has rigorously challenged the
• 14:06
  actuarial assumptions underpinning those $64.6 million in liabilities gives
• 14:11
  investors confidence that RMG is adequately capitalized to meet its future obligations. Exactly.
• 14:17
  It's about peace of mind. So what does this all mean for the future?
• 14:20
  We have established that RMG possesses a fortress balance sheet,
• 14:24
  expanding profit margins, and audited financials that hold up to intense scrutiny.
• 14:28
  But equity markets are forward-looking. Right.
• 14:31
  We must evaluate the macroeconomic risks and future growth catalysts outlined in the documents.
• 14:36
  The reports explicitly acknowledge several macroeconomic headwinds.
• 14:40
  The global economy remains constrained by ongoing trade tensions and persistent
• 14:45
  geopolitical uncertainties. Furthermore, interest rate volatility continues
• 14:49
  to impact capital markets and institutional investor sentiment across the Asian region.
• 14:53
  And adding to those macro pressures is a very specific localized regulatory risk.
• 14:59
  The Singapore Ministry of Health recently intervened to address the escalating
• 15:03
  costs of private health care by introducing a new regulatory framework.
• 15:07
  They mandated a higher co-payment cap, setting the minimum out-of-pocket exposure for patients at $6,000.
• 15:13
  Now, when a government alters the cost-sharing dynamics of healthcare like that,
• 15:18
  it typically causes significant disruption for private insurers.
• 15:21
  It fundamentally changes consumer utilization rates.
• 15:25
  However, RMG's response demonstrated remarkable operational agility.
• 15:30
  They immediately launched a new insurance rider through RHI that fully complies
• 15:35
  with the new copayment regulations.
• 15:36
  And because they were able to pivot their product offerings so swiftly,
• 15:40
  RMG explicitly stated in their guidance that they do not expect this regulatory
• 15:44
  shift to have a material financial impact on their insurance division.
• 15:49
  That really highlights the advantage of having the internal infrastructure and
• 15:52
  capital flexibility to adapt to regulatory shocks in real time.
• 15:56
  It's a huge advantage. And while they are successfully mitigating those regulatory
• 16:00
  and macroeconomic headwinds, RMG is also positioning itself to capture massive
• 16:05
  structural demographic tailwinds.
• 16:08
  If we connect this to the bigger picture, the demographic data in both Singapore
• 16:12
  and China points to two undeniable trends, rapidly aging populations and persistently falling birth rates.
• 16:19
  From a public policy perspective, an aging population presents massive challenges. changes.
• 16:24
  But from an investment perspective in the health care sector,
• 16:26
  it provides a near-guaranteed expansion of the total addressable market.
• 16:30
  Because health care is a highly non-cyclical sector. Right.
• 16:33
  Economic recessions do not reduce the incidence of chronic diseases.
• 16:37
  And an aging demographic requires an exponentially higher volume of medical
• 16:41
  interventions, diagnostics, and long-term care.
• 16:43
  And RMG is proactively evolving their service model to capture this specific demographic demand.
• 16:49
  The reports outline the upcoming launch of the Raffles Healthy Longevity Center.
• 16:53
  Which is scheduled to commence operations in the first quarter of 2026.
• 16:57
  The Longevity Center represents a strategic pivot from traditional reactive
• 17:01
  medicine, treating sickness after it occurs, to proactive preventative care.
• 17:07
  The facility will utilize advanced diagnostics, genetic screening,
• 17:11
  and evidence-based therapies designed to optimize aging.
• 17:15
  They are targeting a growing demographic of affluent consumers who are highly
• 17:19
  willing to spend out-of-pocket discretionary income, not just to extend their
• 17:23
  lifespan, but to maximize their health span.
• 17:26
  The number of years they live in good health. Exactly.
• 17:28
  It is a high-margin, specialized service that diversifies their revenue away
• 17:32
  from standard clinical care.
• 17:34
  Alongside this focus on preventative medicine, the documents also reveal a significant
• 17:38
  commitment to technological transformation.
• 17:41
  Specifically, the early adoption of artificial intelligence across their network.
• 17:46
  The integration of AI in healthcare often starts with back-office administration,
• 17:50
  like automating billing or streamlining appointment schedules.
• 17:53
  But RMG's reports indicate they're looking to embed AI deeper into the actual
• 17:58
  delivery of care, assisting with diagnostics, personalizing treatment plans,
• 18:02
  and optimizing resource allocation within their hospitals.
• 18:05
  The implications for their operational leverage are profound.
• 18:08
  As we discussed earlier, they have already managed to boost their PAM by 13.4%
• 18:13
  and their insurance profits by 50.6% using traditional cost control measures.
• 18:18
  So if they successfully deploy heavily trained AI models into their clinical
• 18:22
  and administrative workflows.
• 18:24
  The resulting efficiencies could radically compress their operating costs,
• 18:28
  driving even steeper margin expansion over the next three to five years.
• 18:32
  It is a compelling trajectory. To synthesize our findings for you,
• 18:35
  the listener, the overriding takeaway from RMG's FY 2025 financial results is
• 18:41
  the sheer resilience of the fully integrated health care model.
• 18:44
  The integration is their definitive economic moat. By controlling the entire
• 18:48
  value chain acting simultaneously as the primary care clinic,
• 18:51
  the tertiary hospital provider, and the insurance payer, they inherently hedge
• 18:56
  their operational risks.
• 18:57
  If third-party medical costs spike due to inflation, standalone insurers suffer.
• 19:03
  But RNG's hospital division benefits from higher billing rates.
• 19:06
  Conversely, they can leverage their hospital ownership to ruthlessly suppress
• 19:10
  claims costs for their insurance arm, generating that 50% profit spike we saw in RHI.
• 19:16
  They capture the financial value at every single touchpoint of the patient journey,
• 19:20
  resulting in a highly defensive cash-generative business.
• 19:25
  As we conclude this analysis, I want to leave you with a final provocative thought
• 19:29
  regarding the future of the healthcare sector.
• 19:30
  Go ahead. We discussed RMG's proactive adoption of artificial intelligence.
• 19:35
  As AI capabilities compound, enabling hyper-personalized, predictive,
• 19:39
  and preventative care that can be administered and monitored remotely in the
• 19:43
  patient's own home, how will that alter the fundamental economics of the integrated
• 19:47
  model? Yeah, it is the big question.
• 19:49
  Currently, the financial center of gravity for RMG and its peers relies on driving
• 19:53
  patient volume into massive capital-intensive physical assets,
• 19:57
  like their $741 million portfolio of hospitals.
• 20:01
  If technology successfully shifts the primary site of care from the tertiary
• 20:05
  hospital to the living room, will those massive physical real estate footprints
• 20:09
  become stranded assets?
• 20:10
  Will it force traditional healthcare giants to entirely reinvent their capital
• 20:14
  allocation strategies?
• 20:15
  It is a systemic risk that every long-term healthcare investor must carefully
• 20:19
  evaluate, a vital strategic question to consider as we monitor the evolution of this sector.
• 20:24
  That concludes our deep dive into RMG's latest financial results.
• 20:28
  Thank you for joining us today. This content is intended to serve strictly and
• 20:32
  only as an informational, independent, objective summary of recent events and
• 20:36
  should in no way be interpreted, construed or relied upon by any party as insight
• 20:40
  information or financial advice.